Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial
Li Zhang(Sun Yat-sen University), Shenglin Ma(Zhejiang Cancer Hospital), Xiangqun Song(Tumor Hospital of Guangxi Medical University), Baohui Han(Shanghai Chest Hospital), Ying Cheng(Jilin Province Tumor Hospital), Cheng Huang(Fujian Provincial Cancer Hospital), Shujun Yang(Henan Cancer Hospital), Xiaoqing Liu(307th Hospital of Chinese People’s Liberation Army), Yunpeng Liu(China Medical University), Shun Lü(Shanghai Chest Hospital), Jie Wang(Peking University Cancer Hospital), Shucai Zhang(Beijing Chest Hospital), Caicun Zhou(Tongji University), Xiangwei Zhang, Nobuya Hayashi(AstraZeneca (United Kingdom)), Mengzhao Wang(Peking Union Medical College Hospital)
Cited by 226
Abstract
Related Papers
No related papers found
Powered by citation graph analysis